We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
PUT
Snap
SNAP
$10.1B
| $12.8M | 0.02% |
+2,885,000
| New | +$15.8M |
2026 Q2
0 quarters
|
|
902
CALL
Cloudflare
NET
$113B
| $12.8M | 0.02% |
52,100
+28,700
| +123% | +$6.28M |
2024 Q1
9 quarters
|
|
903
PUT
SLB Ltd
SLB
$79.3B
| $12.7M | 0.02% |
274,200
-97,000
| -26% | -$5.2M |
2022 Q4
14 quarters
|
|
904
PUT
Wayfair
W
$15.6B
| $12.7M | 0.02% |
137,800
-24,100
| -15% | -$1.78M |
2025 Q1
5 quarters
|
|
905
Opus Genetics
IRD
$306M
| $12.7M | 0.02% |
3,087,866
+369,837
| +14% | +$1.73M |
2025 Q4
2 quarters
|
|
906
Magnite
MGNI
$3.12B
| $12.7M | 0.02% |
666,554
-833,889
| -56% | -$11.9M |
2025 Q4
2 quarters
|
|
907
PUT
Robinhood
HOOD
$82.2B
| $12.6M | 0.02% |
126,000
-31,200
| -20% | -$2.61M |
2024 Q3
7 quarters
|
|
908
PUT
Spotify
SPOT
$111B
| $12.6M | 0.02% |
27,500
+2,000
| +8% | +$953K |
2024 Q4
6 quarters
|
|
909
CALL
Reddit
RDDT
$25.9B
| $12.6M | 0.02% |
72,500
+32,200
| +80% | +$5.16M |
2024 Q4
6 quarters
|
|
910
SunCoke Energy
SXC
$902M
| $12.6M | 0.02% |
1,561,506
-826,614
| -35% | -$6.39M |
2025 Q1
5 quarters
|
|
|
IRLA
911
IRulya Therapeutics Inc. Common Stock
IRLA
$33.5M
| $12.6M | 0.02% |
+69,967
| New | +$1.61M |
2026 Q2
0 quarters
|
|
912
Korro Bio
KRRO
$204M
| $12.5M | 0.02% |
951,783
-88,271
| -8% | -$1.1M |
2026 Q1
1 quarter
|
|
913
CALL
DELISTED
Leggett & Platt
LEG
| $12.5M | 0.02% |
+1,070,900
| New | +$11.3M |
2026 Q2
0 quarters
|
|
914
PUT
Salesforce
CRM
$199B
| $12.5M | 0.02% |
80,000
+14,700
| +23% | +$2.58M |
2022 Q1
17 quarters
|
|
915
American Homes 4 Rent
AMH
$11.2B
| $12.5M | 0.02% |
373,268
-740,330
| -66% | -$23.4M |
2026 Q1
1 quarter
|
|
916
NetEase
NTES
$72B
| $12.5M | 0.02% |
+97,525
| New | +$11.5M |
2026 Q2
0 quarters
|
|
917
CALL
Cisco
CSCO
$435B
| $12.5M | 0.02% |
106,100
+5,000
| +5% | +$523K |
2023 Q1
13 quarters
|
|
918
Monopar Therapeutics
MNPR
$493M
| $12.5M | 0.02% |
134,543
-1,900
| -1% | -$118K |
2025 Q4
2 quarters
|
|
919
Carvana
CVNA
$65B
| $12.4M | 0.02% |
188,952
+151,457
| +404% | +$10.7M |
2023 Q3
11 quarters
|
|
920
Weatherford International
WFRD
$6.44B
| $12.3M | 0.02% |
150,999
+70,372
| +87% | +$7.14M |
2025 Q1
5 quarters
|
|
921
Amylyx Pharmaceuticals
AMLX
$3.52B
| $12.3M | 0.02% |
684,974
-422,297
| -38% | -$6.53M |
2025 Q3
3 quarters
|
|
922
Tutor Perini Cor
TPC
$4.27B
| $12.3M | 0.02% |
+147,923
| New | +$11.9M |
2026 Q2
0 quarters
|
|
923
Kyndryl
KD
$3.07B
| $12.3M | 0.02% |
1,084,033
+757,076
| +232% | +$9.43M |
2025 Q4
2 quarters
|
|
|
924
Robinhood
HOOD
$82.2B
| $12.2M | 0.02% |
122,075
+80,813
| +196% | +$6.77M |
2025 Q4
2 quarters
|
|
925
CALL
Lockheed Martin
LMT
$145B
| $12.2M | 0.02% |
24,000
+23,300
| +3,329% | +$12.6M |
2025 Q2
4 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.